Blog articles

Almost a miracle: gene-edited cells that can cure cancer

Since Layla Richards was cured of acute lymphoblastic leukaemia, attention has turned to the possibilities of genome engineering 

Genomics and the 'healthy smoker'

While smoking is undoubtedly associated with disease, there are smokers who escape. Are they just lucky?

Circulating cell free DNA in pregnancy and cancer

Improved understanding of plasma DNA is opening up new possibilities for non-invasive testing and diagnosis

The modern face of genomic medicine

Genomics England’s new PanelApp is set to encourage shared knowledge and accelerate progress in whole genome sequencing analysis

Progress for personalised cancer therapies

Thanks to a wave of research projects, genomics is beginning to unravel the complexities of cancer and guide treatment for patients

Clinical interpretation: when is a variant a mutation?

Genome sequencing produces volumes of valuable data, but what are the challenges of interpretation that gives practitioners the answers they need?

Genomics and the trouble with 'N of 1' trials

Randomised controlled trials are a rigorous way to identify cause and effect, but when it comes to rare genomic variants, connections can be hard to detect

Novel 'virotherapy' shows promise for skin cancer treatment

Modified virus known as T-vec mounts dual attack on cancer cells

Sequencing cancer DNA - what are the issues?

Whole genome sequencing can reveal vast amounts about how cancer cells work, but the process of discovery is not without challenges

Precision in medicine in action

Genomics can help to target treatments for patients with cancer, rare inherited conditions, and infectious diseases

The 100,000 Genomes Project – sorting fact from fiction

As the first patients are set to be recruited to the main study this month: what are the truths and myths about this Project?

Cancer immunotherapy: genomic insights, promises and challenges

One-in-two people are likely to develop cancer, according to new research. With advances in genomics, can we improve the outcomes?